Pfizer’s Bourla: State of US Presidential Transition Not ‘Ideal’ For Vaccine Rollout

 
• By Sarah Karlin-Smith
  
Pfizer CEO Albert Bourla discussed the company's COVID-19 vaccine on 17 November • Source: STAT Summit
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Distribution/Supply Chain

More from Compliance